Sa10940134 (Talk | contribs) |
|||
Line 330: | Line 330: | ||
<div class="col-8 offset-2"> | <div class="col-8 offset-2"> | ||
<h3>header</h3> | <h3>header</h3> | ||
+ | <h3>Sequence selection and Codon Optimization</h4> | ||
+ | <h4>The previous part (BBa_K1955000) was documented to be acquired from NCBI with no further indication. The sequence of HA strain(A/WSN 1933/TS61(H1N1)) is based on <a href=” https://www.ncbi.nlm.nih.gov/nucleotide/CY010788.1?report=genbank&log$=nuclalign&blast_rank=2&RID=F439K4B5015">NCBI(CY010788.1)</a>, being 7 bp difference to the precious part(Fig.1). </h4> | ||
+ | <h4>To express the target protein, we chose to use BL21 E.coli strain with a pET29a vector. In order to improve the expression efficiency of our chassis, we first codon optimized the sequence and checked for illegal cutting sites using ATGme for E.coli. </h4> | ||
+ | |||
+ | |||
</div> | </div> | ||
</div> | </div> |
Revision as of 14:11, 16 October 2019
![](https://static.igem.org/mediawiki/2019/thumb/c/ca/T--CSMU_Taiwan--gene_red.png/613px-T--CSMU_Taiwan--gene_red.png)
![Avatar](https://static.igem.org/mediawiki/2019/8/88/T--CSMU_Taiwan--student3-1.png)
Sequence Optimization
TEV Cutting Site
Further Applications
Improved Solubility